Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

NCT04030091 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 1

Interventions

DRUG: 3 hours humulin R 100 IU/mL PIT
DRUG: 2 hours humulin R 100 IU/mL PIT

Sponsor

Sciema UG

Collaborators

[object Object]